HiMedia’s COVID-19 Detection Kit detects the BF.7 variant

HiMedia Laboratories announces that their RT-PCR kits are capable of detecting the recently discovered BF.7 SARS-CoV-2 variant. The portfolio includes:

•    MBPCR243 – A 4 Gene COVID-19 Multiplex Detection Kit
•    MBPCR255 – Hi-PCR® Triplex COVID-19 Detection Kit

The company tested the impact of the variant on their Triplex PCR Kit. Mutations, especially in RNA viruses are expected and SARS-CoV-2 is no exception. 

“Multiplexing has the advantage of higher sensitivity as it detects more than one region of the target, while also being capable of detecting mutations. As the new variant is wreaking a havoc worldwide, it becomes imperative to test the accuracy of the existing kits” says Dr Rajas V Warke – Director of HiGenoMB® and Virology, HiMedia Labs.

To determine whether their RT-PCR kits can detect the BF.7 variant of the virus, the R&D team at HiGenoMB® analysed the sequenced data in depth. This CE-IVD and CDSCO approved kit that also detected the earlier variants such as The Delta and Omicron has shown 100% binding, indicating that the new found variant will not hamper the sensitivity of the kit (MBPCR255). 

Dr Rajas adds, “As a leader in Molecular diagnostics, HiMedia® is committed to developing reliable, fast and accurate diagnostic kits that are an important tool to assess and contain the spread of virus.”

Please visit our website www.himedialabs.com for more details about HiGenoMB® products related to COVID Molecular testing.

*This press release is published by team VOH.*

Partners & Associate